iShares Nasdaq Biotechnology ETF Stock Forecast, Price & News

iShares Nasdaq Biotechnology ETF's stock was trading at $106.97 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IBB stock has increased by 27.4% and is now trading at $136.32.
View which stocks have been most impacted by COVID-19.

iShares Nasdaq Biotechnology ETF announced a quarterly dividend on Wednesday, March 25th. Stockholders of record on Thursday, March 26th will be given a dividend of $0.0554 per share on Tuesday, March 31st. This represents a $0.22 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date is Wednesday, March 25th.
View iShares Nasdaq Biotechnology ETF's dividend history.

iShares Nasdaq Biotechnology ETF shares split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were payable to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

Some companies that are related to iShares Nasdaq Biotechnology ETF include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tri-Continental (TY), Gabelli Equity Trust (GAB), Hercules Capital (HTGC), Royce Value Trust (RVT), Liberty All-Star Equity Fund (USA), Boulder Growth & Income Fund (BIF), AllianceBernstein Global Hgh Incm Fd (AWF), SPDR Bloomberg Barclays International Treasury Bond ETF (BWX), Blackrock Muniyield Insured Fund (MYI), Tekla Healthcare Investors (HQH) and Tortoise Energy Infrastructure (TYG).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Alibaba Group (BABA), Netflix (NFLX), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and Paypal (PYPL).

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

iShares Nasdaq Biotechnology ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include CHURCHILL MANAGEMENT Corp (2.24%), PNC Financial Services Group Inc. (0.94%), Envestnet Asset Management Inc. (0.60%), QVT Financial LP (0.44%), Total Investment Management Inc. (0.42%) and First Republic Investment Management Inc. (0.38%).

IBB stock was sold by a variety of institutional investors in the last quarter, including Advisor Group Holdings Inc., Estate Counselors LLC, Sawtooth Solutions LLC, AE Wealth Management LLC, Janney Capital Management LLC, Glenmede Trust Co. NA, Bank of Nova Scotia, and Simplex Trading LLC.

IBB stock was bought by a variety of institutional investors in the last quarter, including CHURCHILL MANAGEMENT Corp, Envestnet Asset Management Inc., Total Investment Management Inc., Stadion Money Management LLC, Advisors Preferred LLC, DAVENPORT & Co LLC, SG Americas Securities LLC, and QVT Financial LP.

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IBB stock can currently be purchased for approximately $136.32.

iShares Nasdaq Biotechnology ETF has a market capitalization of $9.27 billion.